Quantbot Technologies LP Cure Vac N.V. Transaction History

Quantbot Technologies LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$2.94 - $4.34 $13,188 - $19,469	4,486 New	4,486 $13,000
Q4 2022 Feb 13, 2023	BUY	$5.75 - $8.5 $5,175 - $7,650	900 New	900 $5,000
Q2 2022 Aug 09, 2022	BUY	$13.18 - $19.41 $28,996 - $42,702	2,200 Added 17.46%	14,800 $201,000
Q1 2022 May 16, 2022	BUY	$14.73 - $35.25 $185,598 - $444,150	12,600 New	12,600 $247,000

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $538M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.